GLP-1 · Menopause metabolism
Ozempic for menopause: weight gain, insulin resistance, and hot flashes
Menopause weight gain has a specific biology: declining estrogen, rising visceral fat, insulin resistance, and a stubbornly reset appetite set point. Ozempic (semaglutide) directly hits three of those four levers. That's why it works so well in midlife women — and why it's the most-searched drug on menopause forums.
Why Ozempic works better in menopause than at other life stages
Menopause weight gain is not "eating too much." It's a shift in energy partitioning driven by falling estrogen, rising cortisol reactivity, and worsening insulin sensitivity. GLP-1 receptor agonists like Ozempic address the underlying biology — they slow gastric emptying, improve insulin sensitivity, reduce reward-driven eating, and reduce visceral fat preferentially.
What it does well
- 15% body-weight loss average at 68 weeks
- Preferential reduction of visceral adiposity
- Improved fasting glucose and A1c
- Reduced cardiovascular events (SELECT trial)
What it doesn't do
Ozempic does not treat estrogen deficiency. It won't fix hot flashes, vaginal dryness, sleep disruption, or bone loss. Combining it with appropriate HRT is often the most effective approach for the whole menopause syndrome.
Side effects to know
Nausea (most common, transient), constipation, delayed gastric emptying, rare pancreatitis. Muscle mass loss can accompany rapid weight loss — pair with resistance training and adequate protein (0.8–1.0 g per lb of goal body weight).
Frequently asked questions
How much weight can you lose on Ozempic in menopause?
STEP-1 trial: 15% mean body-weight loss at 68 weeks on 2.4 mg semaglutide. Menopausal subgroup analyses show similar or slightly better results.
Does Ozempic help hot flashes?
Emerging observational data suggests some women report reduced hot flashes on GLP-1s, likely mediated by weight loss and inflammation reduction. Not yet studied in RCTs.
Ozempic vs Wegovy for menopause?
Same drug (semaglutide). Ozempic is FDA-approved for type 2 diabetes; Wegovy is FDA-approved for obesity. Insurance coverage differs.
Do you keep the weight off after stopping Ozempic?
Most women regain 2/3 of the weight within a year of stopping, per the STEP-4 trial. This is why long-term or intermittent maintenance dosing is now common.
Can you take Ozempic with HRT?
Yes — there is no known interaction with estradiol or progesterone. Many women use both simultaneously to address the metabolic and hormonal drivers of menopause weight gain together.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.